Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Phase I Study of BI 754091 Monotherapy and Combination Therapy of BI 754091 and BI 754111 in Asian Patients With Advanced Solid Tumours

NCT03433898 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03433898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Phase I Study of BI 754091 Monotherapy and Combination Therapy of BI 754091 and BI 754111 in Asian Patients With Advanced Solid Tumours
Lead sponsor
Boehringer Ingelheim
Phase
Phase 1
Overall status
Completed
Start date
February 23, 2018
Completion date
July 20, 2023
Enrollment
146 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms